Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)

Sophie A. Bell, Hannah R. Cohen, Seonjoo Lee, Hyun Kim, Adam Ciarleglio, Howard Andrews, Andres M. Rivera, Kay Igwe, Adam M. Brickman, D.P. Devanand, Philip D. Harvey, Lon S. Schneider, Terry E. Goldberg
doi: https://doi.org/10.1101/2021.01.13.21249627

Article usage

Article usage: January 2021 to July 2025

AbstractFullPdf
Jan 20214521470
Feb 20211841419
Mar 2021831115
Apr 202189311
May 202172410
Jun 202177410
Jul 202123214
Aug 202132710
Sep 202127114
Oct 202128421
Nov 202139229
Dec 202123111
Jan 20222458
Feb 20222323
Mar 20222915
Apr 20222603
May 202216313
Jun 202218111
Jul 20221410
Aug 202233511
Sep 202230314
Oct 20222917
Nov 20221822
Dec 20221216
Jan 20231725
Feb 20231143
Mar 20231302
Apr 20232124
May 20238210
Jun 2023840
Jul 2023514
Aug 202314126
Sep 2023843
Oct 2023500
Nov 20231043
Dec 20231007
Jan 2024402
Feb 20241328
Mar 2024913
Apr 2024856
May 2024733
Jun 20241326
Jul 2024504
Aug 20242027
Sep 20241825
Oct 2024654
Nov 202411111
Dec 2024538
Jan 20257311
Feb 20256178
Mar 2025123010
Apr 202541411
May 202515714
Jun 2025151810
Jul 2025533
Back to top
Posted January 16, 2021.
Download PDF
Data/Code
Email
Development of Novel Measures for Alzheimer’s Disease Prevention Trials (NoMAD)
Sophie A. Bell, Hannah R. Cohen, Seonjoo Lee, Hyun Kim, Adam Ciarleglio, Howard Andrews, Andres M. Rivera, Kay Igwe, Adam M. Brickman, D.P. Devanand, Philip D. Harvey, Lon S. Schneider, Terry E. Goldberg
medRxiv 2021.01.13.21249627; doi: https://doi.org/10.1101/2021.01.13.21249627
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area